Atlas Arteria (ASX:ALX) - CEO, Graeme Bevans
CEO, Graeme Bevans
Source: Financial Review
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Despite only being announced yesterday, toll road operator Atlas Arteria (ALX) has successfully completed a $420 million placement
  • Approximately 67.7 million new fully paid shares were issued to domestic and offshore institutional investors at a price of $6.20 per share
  • Atlas Arteria will use this money to boost its finances after motorists stayed home during the COVID-19 pandemic and did not pay tolls
  • The company will now undertake a share purchase plan to raise an additional $75 million
  • Atlas Arteria is down a slight 2.09 per cent on the market and shares are trading for $6.56 each

Despite only being announced yesterday, toll road operator Atlas Arteria (ALX) has successfully completed a $420 million placement.

Approximately 67.7 million new fully paid shares were issued to domestic and offshore institutional investors at a price of $6.20 per share.

This price represented a 7.5 per cent discount to the last trading price of $6.70 on May 27, and an 8.2 per cent discount to the five-day volume-weighted average price up to close on May 27, which hit $6.76.

As the placement was oversubscribed, shareholders who bid for an amount either less or equal than their pro-rata amount received what they applied for.

Shares under the placement are expected to settle on June 2 and be allocated and begin trading the ASX on June 3.

Atlas Arteria will use this money to boost its finances after motorists stayed home during the COVID-19 pandemic and did not pay tolls and repay a loan to MIBL Finance of Luxembourg.

“We are very pleased with the significant support for the transaction. The repayment of the MIBL Facility will deliver a stronger, more resilient balance sheet and improve our flexibility to pursue future growth opportunities,” CEO Graeme Bevans said.

Atlas Arteria will now undertake a share purchase plan to raise an additional $75 million.

The share purchase plan will open on June 5, close on June 25, and shares can begin trading on the ASX on July 3.

Atlas Arteria is down a slight 2.09 per cent on the market and shares are trading for $6.56 each at 2:29 pm AEST.

ALX by the numbers
More From The Market Herald

" Appen (ASX:APX) positioned to weather pandemic, reaffirms guidance

Data annotation and artificial intelligence company Appen (ASX:APX) has today reaffirmed its guidance for the 2020…

" Appen (ASX:APX) beats earnings guidance, outperforms a weak market

Data annotation and artificial intelligence specialist Appen (APX) has soared today after beating its earnings guidance…
Appen (ASX:APX) - CEO, Mark Brayan

" Appen’s (ASX:APX) shares rise on business restructure

Machine intelligence company Appen (ASX:APX) has made some changes to the structure of its business.
The Market Herald Video

" Appen (ASX:APX) receives $1.17b takeover bid from Canadian tech giant

Appen (ASX:APX) has received an unsolicited $1.17 billion takeover bid from Canadian telco giant Telus International.